Predicted oxygenation efficacy of a thoracic artificial lung

Carrie E. Perlman, Lyle F. Mockros

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

A thoracic artificial lung (TAL) provides respiratory support for lung disease. How well a TAL improves blood oxygenation for a specific pathology depends on how the TAL is attached to the pulmonary circulation: in series with the natural lungs (NLs), in parallel, or in a hybrid series/parallel combination. A computational model, including hemodynamic and O2 and CO2 exchange components, predicts TAL effects on blood flow rates and gas transport in pulmonary disease states modeled by elevated pulmonary vascular resistance (PVR) or reduced oxygen diffusivity in the NLs. In most cases, parallel and series TAL attachment provide comparable, maximal oxygenation. Series, with passage of total cardiac output (CO) through the NLs, is preferred for its filtration of emboli. Hybrid TAL attachment is more complicated, requiring a third graft, yet oxygenates less well than parallel and series. With extreme elevations of PVR, as in primary pulmonary hypertension, parallel TAL attachment provides an oxygenating shunt around the high resistance of the NLs, thus unloading the right ventricle, normalizing CO, and maximizing oxygenation.

Original languageEnglish
Pages (from-to)247-254
Number of pages8
JournalASAIO Journal
Volume58
Issue number3
DOIs
StatePublished - May 2012

Fingerprint

Dive into the research topics of 'Predicted oxygenation efficacy of a thoracic artificial lung'. Together they form a unique fingerprint.

Cite this